IceCure Medical (ICCM) Debt to Equity (2020 - 2025)

IceCure Medical (ICCM) reported Debt to Equity of $0.0 for Q4 2025, down 93.84% year-over-year from $0.02 in Q4 2024, and down 93.84% quarter-over-quarter from $0.02 in Q4 2024.

IceCure Medical (ICCM) Debt to Equity (2020 - 2025) Analysis & Trends

IceCure Medical (ICCM) has 4 years of Debt to Equity data on file, last reported at $0.0 in Q4 2025.

  • Debt to Equity for Q4 2025 came in at $0.0, down 93.84% year-over-year; the trailing twelve-month figure through Dec 2025 was $0.0 (down 93.84% YoY), and the FY2025 annual result was $0.0, down 93.84% from the prior year.
  • Debt to Equity retreated to $0.0 in Q4 2025 per ICCM's latest filing, from $0.02 in the prior quarter.
  • Over five years, Debt to Equity peaked at $0.02 in Q4 2024 and troughed at $0.0 in Q4 2025.
  • A 3-year average of $0.02 and a median of $0.02 in 2021 frame the typical range for Debt to Equity.
  • The sharpest annual moves came in 2021 and 2025: Debt to Equity sank 82.94% in 2021, then slumped 93.84% in 2025.
  • A 3-year view of Debt to Equity shows it stood at $0.02 in 2021, then climbed by 1.77% to $0.02 in 2024, then tumbled by 93.84% to $0.0 in 2025.
  • Business Quant data shows ICCM's Debt to Equity at $0.0 in Q4 2025, $0.02 in Q4 2024, and $0.02 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 0.65
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 0.64
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 0.57
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 0.42
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 0.06
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.71
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 0.95
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 0.27
10 IceCure Medical 334.80 -8.11 Mn 295,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2025 0.00
Dec 31, 2024 0.02
Dec 31, 2021 0.02
Dec 31, 2020 0.13